1
|
Giorgioni G, Bonifazi A, Botticelli L, Cifani C, Matteucci F, Micioni Di Bonaventura E, Micioni Di Bonaventura MV, Giannella M, Piergentili A, Piergentili A, Quaglia W, Del Bello F. Advances in drug design and therapeutic potential of selective or multitarget 5-HT1A receptor ligands. Med Res Rev 2024; 44:2640-2706. [PMID: 38808959 DOI: 10.1002/med.22049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2023] [Revised: 03/14/2024] [Accepted: 05/03/2024] [Indexed: 05/30/2024]
Abstract
5-HT1A receptor (5-HT1A-R) is a serotoninergic G-protein coupled receptor subtype which contributes to several physiological processes in both central nervous system and periphery. Despite being the first 5-HT-R identified, cloned and studied, it still represents a very attractive target in drug discovery and continues to be the focus of a myriad of drug discovery campaigns due to its involvement in numerous neuropsychiatric disorders. The structure-activity relationship studies (SAR) performed over the last years have been devoted to three main goals: (i) design and synthesis of 5-HT1A-R selective/preferential ligands; (ii) identification of 5-HT1A-R biased agonists, differentiating pre- versus post-synaptic agonism and signaling cellular mechanisms; (iii) development of multitarget compounds endowed with well-defined poly-pharmacological profiles targeting 5-HT1A-R along with other serotonin receptors, serotonin transporter (SERT), D2-like receptors and/or enzymes, such as acetylcholinesterase and phosphodiesterase, as a promising strategy for the management of complex psychiatric and neurodegenerative disorders. In this review, medicinal chemistry aspects of ligands acting as selective/preferential or multitarget 5-HT1A-R agonists and antagonists belonging to different chemotypes and developed in the last 7 years (2017-2023) have been discussed. The development of chemical and pharmacological 5-HT1A-R tools for molecular imaging have also been described. Finally, the pharmacological interest of 5-HT1A-R and the therapeutic potential of ligands targeting this receptor have been considered.
Collapse
Affiliation(s)
- Gianfabio Giorgioni
- Medicinal Chemistry Unit, School of Pharmacy, University of Camerino, Camerino, Italy
| | - Alessandro Bonifazi
- Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health, Baltimore, Maryland, USA
| | - Luca Botticelli
- Pharmacology Unit, School of Pharmacy, University of Camerino, Camerino, Italy
| | - Carlo Cifani
- Pharmacology Unit, School of Pharmacy, University of Camerino, Camerino, Italy
| | - Federica Matteucci
- Medicinal Chemistry Unit, School of Pharmacy, University of Camerino, Camerino, Italy
| | | | | | - Mario Giannella
- Medicinal Chemistry Unit, School of Pharmacy, University of Camerino, Camerino, Italy
| | | | - Alessia Piergentili
- Medicinal Chemistry Unit, School of Pharmacy, University of Camerino, Camerino, Italy
| | - Wilma Quaglia
- Medicinal Chemistry Unit, School of Pharmacy, University of Camerino, Camerino, Italy
| | - Fabio Del Bello
- Medicinal Chemistry Unit, School of Pharmacy, University of Camerino, Camerino, Italy
| |
Collapse
|
2
|
Andreozzi G, Ambrosio MR, Magli E, Maneli G, Severino B, Corvino A, Sparaco R, Perissutti E, Frecentese F, Santagada V, Leśniak A, Bujalska-Zadrożny M, Caliendo G, Formisano P, Fiorino F. Design, Synthesis and Biological Evaluation of Novel N-Arylpiperazines Containing a 4,5-Dihydrothiazole Ring. Pharmaceuticals (Basel) 2023; 16:1483. [PMID: 37895954 PMCID: PMC10609883 DOI: 10.3390/ph16101483] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2023] [Revised: 10/03/2023] [Accepted: 10/16/2023] [Indexed: 10/29/2023] Open
Abstract
Arylpiperazines represent one of the most important classes of 5-HT1AR ligands and have attracted considerable interests for their versatile properties in chemistry and pharmacology, leading to the research of new derivatives that has been focused on the modification of one or more portions of such pharmacophore. An efficient protocol for the synthesis of novel thiazolinylphenyl-piperazines (2a-c) and the corresponding acetylated derivatives was used (3a-c). The new compounds were tested for their functional activity and affinity at 5-HT1A receptors, showing an interesting affinity profile with a Ki value of 412 nM for compound 2b. The cytotoxic activity of novel thiazolinylphenyl-piperazines (2a-c) and corresponding N-acetyl derivatives (3a-c) against human prostate and breast cancer cell lines (LNCAP, DU-145 and PC-3, MCF-7, SKBR-3 and MDA-MB231) was investigated according to the procedure described in the literature. The reported data showed a cytotoxic effect for 2a-c and 3a-c compounds (IC50 values ranging from 15 µM to 73 µM) on the investigated cancer cell lines, with no effect on noncancer cells. Future studies will be aimed to investigate the mechanism of action and therapeutic prospects of these new scaffolds.
Collapse
Affiliation(s)
- Giorgia Andreozzi
- Dipartimento di Farmacia, Università di Napoli Federico II, Via D. Montesano, 49, 80131 Naples, Italy; (G.A.); (B.S.); (A.C.); (R.S.); (E.P.); (F.F.); (V.S.); (G.C.)
| | - Maria Rosaria Ambrosio
- URT “Genomic of Diabetes”, Institute for Experimental Endocrinology and Oncology “G. Salvatore”, National Research Council (IEOS-CNR), Via Pansini 5, 80131 Naples, Italy; (M.R.A.); (P.F.)
| | - Elisa Magli
- Dipartimento di Sanità Pubblica, Università di Napoli Federico II, Via Pansini, 5, 80131, Naples, Italy;
| | - Giovanni Maneli
- Department of Translational Medicine, University of Naples “Federico II”, Via Pansini 5, 80131 Naples, Italy;
| | - Beatrice Severino
- Dipartimento di Farmacia, Università di Napoli Federico II, Via D. Montesano, 49, 80131 Naples, Italy; (G.A.); (B.S.); (A.C.); (R.S.); (E.P.); (F.F.); (V.S.); (G.C.)
| | - Angela Corvino
- Dipartimento di Farmacia, Università di Napoli Federico II, Via D. Montesano, 49, 80131 Naples, Italy; (G.A.); (B.S.); (A.C.); (R.S.); (E.P.); (F.F.); (V.S.); (G.C.)
| | - Rosa Sparaco
- Dipartimento di Farmacia, Università di Napoli Federico II, Via D. Montesano, 49, 80131 Naples, Italy; (G.A.); (B.S.); (A.C.); (R.S.); (E.P.); (F.F.); (V.S.); (G.C.)
| | - Elisa Perissutti
- Dipartimento di Farmacia, Università di Napoli Federico II, Via D. Montesano, 49, 80131 Naples, Italy; (G.A.); (B.S.); (A.C.); (R.S.); (E.P.); (F.F.); (V.S.); (G.C.)
| | - Francesco Frecentese
- Dipartimento di Farmacia, Università di Napoli Federico II, Via D. Montesano, 49, 80131 Naples, Italy; (G.A.); (B.S.); (A.C.); (R.S.); (E.P.); (F.F.); (V.S.); (G.C.)
| | - Vincenzo Santagada
- Dipartimento di Farmacia, Università di Napoli Federico II, Via D. Montesano, 49, 80131 Naples, Italy; (G.A.); (B.S.); (A.C.); (R.S.); (E.P.); (F.F.); (V.S.); (G.C.)
| | - Anna Leśniak
- Department of Pharmacotherapy and Pharmaceutical Care, Centre for Preclinical Research and Technology, Faculty of Pharmacy, Medical University of Warsaw, 1 Banacha Str., 02-097 Warsaw, Poland; (A.L.); (M.B.-Z.)
| | - Magdalena Bujalska-Zadrożny
- Department of Pharmacotherapy and Pharmaceutical Care, Centre for Preclinical Research and Technology, Faculty of Pharmacy, Medical University of Warsaw, 1 Banacha Str., 02-097 Warsaw, Poland; (A.L.); (M.B.-Z.)
| | - Giuseppe Caliendo
- Dipartimento di Farmacia, Università di Napoli Federico II, Via D. Montesano, 49, 80131 Naples, Italy; (G.A.); (B.S.); (A.C.); (R.S.); (E.P.); (F.F.); (V.S.); (G.C.)
| | - Pietro Formisano
- URT “Genomic of Diabetes”, Institute for Experimental Endocrinology and Oncology “G. Salvatore”, National Research Council (IEOS-CNR), Via Pansini 5, 80131 Naples, Italy; (M.R.A.); (P.F.)
- Department of Translational Medicine, University of Naples “Federico II”, Via Pansini 5, 80131 Naples, Italy;
| | - Ferdinando Fiorino
- Dipartimento di Farmacia, Università di Napoli Federico II, Via D. Montesano, 49, 80131 Naples, Italy; (G.A.); (B.S.); (A.C.); (R.S.); (E.P.); (F.F.); (V.S.); (G.C.)
| |
Collapse
|
3
|
Synthesis, Docking Studies and Pharmacological Evaluation of Serotoninergic Ligands Containing a 5-Norbornene-2-Carboxamide Nucleus. MOLECULES (BASEL, SWITZERLAND) 2022; 27:molecules27196492. [PMID: 36235029 PMCID: PMC9572521 DOI: 10.3390/molecules27196492] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/29/2022] [Revised: 09/20/2022] [Accepted: 09/28/2022] [Indexed: 11/09/2022]
Abstract
A new series of 5-norbornene-2-carboxamide derivatives was prepared and their affinities to the 5-HT1A, 5-HT2A, and 5-HT2C receptors were evaluated and compared to a previously synthesized series of derivatives characterized by exo-N-hydroxy-5-norbornene-2,3-dicarboximidenucleus, in order to identify selective ligands for the above-mentioned subtype receptors. Arylpiperazines represents one of the most important classes of 5-HT1AR ligands, and recent research concerning new derivatives has been focused on the modification of one or more portions of such pharmacophore. The combination of structural elements (heterocyclic nucleus, propyl chain and 4-substituted piperazine), known to be critical to the affinity to 5-HT1A receptors, and the proper selection of substituents led to compounds with high specificity and affinity towards serotoninergic receptors. The most active compounds were selected for further in vivo assays to determine their functional activity. Finally, to rationalize the obtained results, molecular docking studies were performed. The results of the pharmacological studies showed that Norbo-4 and Norbo-18 were the most active and promising derivatives for the serotonin receptor considered in this study.
Collapse
|
4
|
Ambrosio MR, Magli E, Caliendo G, Sparaco R, Massarelli P, D'Esposito V, Migliaccio T, Mosca G, Fiorino F, Formisano P. Serotoninergic receptor ligands improve Tamoxifen effectiveness on breast cancer cells. BMC Cancer 2022; 22:171. [PMID: 35168555 PMCID: PMC8845285 DOI: 10.1186/s12885-021-09147-y] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2021] [Accepted: 12/20/2021] [Indexed: 01/19/2023] Open
Abstract
Background Serotonin (or 5-Hydroxytryptamine, 5-HT) signals in mammary gland becomes dysregulated in cancer, also contributing to proliferation, metastasis, and angiogenesis. Thus, the discovery of novel compounds targeting serotonin signaling may contribute to tailor new therapeutic strategies usable in combination with endocrine therapies. We have previously synthesized serotoninergic receptor ligands (SER) with high affinity and selectivity towards 5-HT2A and 5-HT2C receptors, the main mediators of mitogenic effect of serotonin in breast cancer (BC). Here, we investigated the effect of 10 SER on viability of MCF7, SKBR3 and MDA-MB231 BC cells and focused on their potential ability to affect Tamoxifen responsiveness in ER+ cells. Methods Cell viability has been assessed by sulforhodamine B assay. Cell cycle has been analyzed by flow cytometry. Gene expression of 5-HT receptors and Connective Tissue Growth Factor (CTGF) has been checked by RT-PCR; mRNA levels of CTGF and ABC transporters have been further measured by qPCR. Protein levels of 5-HT2C receptors have been analyzed by Western blot. All data were statistically analyzed using GraphPad Prism 7. Results We found that treatment with SER for 72 h reduced viability of BC cells. SER were more effective on MCF7 ER+ cells (IC50 range 10.2 μM - 99.2 μM) compared to SKBR3 (IC50 range 43.3 μM - 260 μM) and MDA-MB231 BC cells (IC50 range 91.3 μM - 306 μM). This was paralleled by accumulation of cells in G0/G1 phase of cell cycle. Next, we provided evidence that two ligands, SER79 and SER68, improved the effectiveness of Tamoxifen treatment in MCF7 cells and modulated the expression of CTGF, without affecting viability of MCF10A non-cancer breast epithelial cells. In a cell model of Tamoxifen resistance, SER68 also restored drug effect independently of CTGF. Conclusions These results identified serotoninergic receptor ligands potentially usable in combination with Tamoxifen to improve its effectiveness on ER+ BC patients. Supplementary Information The online version contains supplementary material available at 10.1186/s12885-021-09147-y.
Collapse
Affiliation(s)
- Maria Rosaria Ambrosio
- Institute for Experimental Endocrinology and Oncology "G. Salvatore" - National Research Council (IEOS-CNR), Via Pansini 5, 80131, Naples, Italy.,Department of Translational Medicine, University of Naples "Federico II" (DiSMeT-UniNa), Via Pansini 5, 80131, Naples, Italy
| | - Elisa Magli
- Department of Pharmacy, University of Naples "Federico II" (UniNa), Via Montesano 49 -, 80131, Naples, Italy
| | - Giuseppe Caliendo
- Department of Pharmacy, University of Naples "Federico II" (UniNa), Via Montesano 49 -, 80131, Naples, Italy
| | - Rosa Sparaco
- Department of Pharmacy, University of Naples "Federico II" (UniNa), Via Montesano 49 -, 80131, Naples, Italy
| | - Paola Massarelli
- Department of Medicine, Surgery and Neuroscience, University of Siena, Strada delle Scotte 6 -, 53100, Siena, Italy
| | - Vittoria D'Esposito
- Institute for Experimental Endocrinology and Oncology "G. Salvatore" - National Research Council (IEOS-CNR), Via Pansini 5, 80131, Naples, Italy.,Department of Translational Medicine, University of Naples "Federico II" (DiSMeT-UniNa), Via Pansini 5, 80131, Naples, Italy
| | - Teresa Migliaccio
- Department of Translational Medicine, University of Naples "Federico II" (DiSMeT-UniNa), Via Pansini 5, 80131, Naples, Italy
| | - Giusy Mosca
- Department of Translational Medicine, University of Naples "Federico II" (DiSMeT-UniNa), Via Pansini 5, 80131, Naples, Italy
| | - Ferdinando Fiorino
- Department of Pharmacy, University of Naples "Federico II" (UniNa), Via Montesano 49 -, 80131, Naples, Italy
| | - Pietro Formisano
- Institute for Experimental Endocrinology and Oncology "G. Salvatore" - National Research Council (IEOS-CNR), Via Pansini 5, 80131, Naples, Italy. .,Department of Translational Medicine, University of Naples "Federico II" (DiSMeT-UniNa), Via Pansini 5, 80131, Naples, Italy.
| |
Collapse
|
5
|
Jiang YP, Jin Y, Bao J, Wang S, Lai WD, Wen CP, Xu ZH, Yu J. Inconsistent Time-Dependent Effects of Tetramethylpyrazine on Primary Neurological Disorders and Psychiatric Comorbidities. Front Pharmacol 2021; 12:708517. [PMID: 34489702 PMCID: PMC8417558 DOI: 10.3389/fphar.2021.708517] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2021] [Accepted: 07/19/2021] [Indexed: 12/26/2022] Open
Abstract
The aim of this study was to investigate the time dependent effects of tetramethylpyrazine (TMP, main activity compound of Ligusticum chuanxiong Hort) on two neurological disorders and their neuropsychiatric comorbidities. 6 Hz corneal rapid kindling was used to induce epileptogenesis and the inflammatory pain was induced by intra-articular Complete Freund's adjuvant (CFA) injection. The mechanical pain thresholds were measured using von Frey hair (D4, D11, D18, D25 after CFA first injection), and the vertical rearings of the mice was observed. To test the neuropsychiatric comorbidities, anxiety-like behaviors of mice were examined by open field and elevated plus maze tests. Two behavioral despair models, tail suspension test and forced swimming test were also used to evaluate the depressive like behaviors. The results showed that TMP administered from the initial day (D1-D35 in kindling model, D0-D14 and D0-D28 in CFA model) of modeling retarded both the developments of 6 Hz corneal rapid kindling epileptogenesis and the CFA induced inflammatory pain. In comparison, late periods administration of TMP (D21-D35 in kindling and D14-D28 in CFA model) showed no effect on the epileptogenesis and the generalized seizures (GS) of kindling, but alleviated maintenance of CFA induced inflammatory pain. Furthermore, we also found all TMP treatments from the initial day of modeling alleviated the co-morbid depressive and anxiety-like behaviors in both models; however, late periods treatments did not, either in kindling or the CFA induced inflammatory pain. BDNF/ERK signaling impairment was also tested by western blot, and the results showed that TMP administered from the initial day of modeling increased the hippocampal BDNF/ERK expression, whereas late period administration showed no effects. Overall, our findings reveal the inconsistent time dependent effects of Tetramethylpyrazine on neurological disorders and their relative neuropsychiatric comorbidities, and provide novel insight into the early application of TMP that might enhance hippocampal BDNF/ERK signaling to alleviate neuropsychiatric comorbidities in neurological diseases.
Collapse
Affiliation(s)
- Yue-Peng Jiang
- College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, China
| | - Yan Jin
- Second Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, China
| | - Jie Bao
- College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, China
| | - Song Wang
- College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, China
| | - Wei-Dong Lai
- College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, China
| | - Cheng-Ping Wen
- College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, China
| | - Zheng-Hao Xu
- College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, China.,Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, Hangzhou, China
| | - Jie Yu
- College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, China.,Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, Hangzhou, China
| |
Collapse
|
6
|
Yaqoob S, Nasim N, Khanam R, Wang Y, Jabeen A, Qureshi U, Ul-Haq Z, El-Seedi HR, Jiang ZH, Khan FA. Synthesis of Highly Potent Anti-Inflammatory Compounds (ROS Inhibitors) from Isonicotinic Acid. Molecules 2021; 26:1272. [PMID: 33652837 PMCID: PMC7956706 DOI: 10.3390/molecules26051272] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2021] [Revised: 02/22/2021] [Accepted: 02/23/2021] [Indexed: 11/16/2022] Open
Abstract
In search of anti-inflammatory compounds, novel scaffolds containing isonicotinoyl motif were synthesized via an efficient strategy. The compounds were screened for their in vitro anti-inflammatory activity. Remarkably high activities were observed for isonicotinates 5-6 and 8a-8b. The compound 5 exhibits an exceptional IC50 value (1.42 ± 0.1 µg/mL) with 95.9% inhibition at 25 µg/mL, which is eight folds better than the standard drug ibuprofen (11.2 ± 1.9 µg/mL). To gain an insight into the mode of action of anti-inflammatory compounds, molecular docking studies were also performed. Decisively, further development and fine tuning of these isonicotinates based scaffolds for the treatment of various aberrations is still a wide-open field of research.
Collapse
Affiliation(s)
- Sana Yaqoob
- Third World Center for Science and Technology, H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan; (S.Y.); (N.N.); (R.K.); (Y.W.); (U.Q.); (Z.U.-H.)
| | - Nourina Nasim
- Third World Center for Science and Technology, H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan; (S.Y.); (N.N.); (R.K.); (Y.W.); (U.Q.); (Z.U.-H.)
| | - Rahila Khanam
- Third World Center for Science and Technology, H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan; (S.Y.); (N.N.); (R.K.); (Y.W.); (U.Q.); (Z.U.-H.)
| | - Yan Wang
- Third World Center for Science and Technology, H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan; (S.Y.); (N.N.); (R.K.); (Y.W.); (U.Q.); (Z.U.-H.)
| | - Almas Jabeen
- Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan;
| | - Urooj Qureshi
- Third World Center for Science and Technology, H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan; (S.Y.); (N.N.); (R.K.); (Y.W.); (U.Q.); (Z.U.-H.)
| | - Zaheer Ul-Haq
- Third World Center for Science and Technology, H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan; (S.Y.); (N.N.); (R.K.); (Y.W.); (U.Q.); (Z.U.-H.)
- Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan;
| | - Hesham R. El-Seedi
- International Research Center for Food Nutrition and Safety, Jiangsu University, Zhenjiang 212013, China
- Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, S-106 91 Stockholm, Sweden
- Department of Chemistry, Faculty of Science, Menoufia University, Menoufia 32511, Egypt
| | - Zi-Hua Jiang
- Department of Chemistry, Lakehead University, 955 Oliver Road, Thunder Bay, ON P7B 5E1, Canada;
| | - Farooq-Ahmad Khan
- Third World Center for Science and Technology, H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan; (S.Y.); (N.N.); (R.K.); (Y.W.); (U.Q.); (Z.U.-H.)
| |
Collapse
|
7
|
Magli E, Kędzierska E, Kaczor AA, Bielenica A, Severino B, Gibuła-Tarłowska E, Kotlińska JH, Corvino A, Sparaco R, Esposito G, Albrizio S, Perissutti E, Frecentese F, Leśniak A, Bujalska-Zadrożny M, Struga M, Capasso R, Santagada V, Caliendo G, Fiorino F. Synthesis, docking studies, and pharmacological evaluation of 2-hydroxypropyl-4-arylpiperazine derivatives as serotoninergic ligands. Arch Pharm (Weinheim) 2021; 354:e2000414. [PMID: 33543794 DOI: 10.1002/ardp.202000414] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2020] [Revised: 12/17/2020] [Accepted: 01/08/2021] [Indexed: 01/02/2023]
Abstract
A new series of norbornene and exo-N-hydroxy-7-oxabicyclo[2.2.1]hept-5-ene-2,3-dicarboximide derivatives was prepared, and their affinities to the 5-HT1A , 5-HT2A , and 5-HT2C receptors were evaluated and compared with a previously synthesized series of derivatives characterized by the same nuclei, to identify selective ligands for the subtype receptors. Arylpiperazines represent one of the most important classes of 5-HT1A R ligands, and the research of new derivatives has been focused on the modification of one or more portions of this pharmacophore. The combination of structural elements (heterocyclic nucleus, hydroxyalkyl chain, and 4-substituted piperazine), known to be critical for the affinity to 5-HT1A receptors, and the proper selection of substituents resulted in compounds with high specificity and affinity toward serotoninergic receptors. The most active compounds were selected for further in vivo assays to determine their functional activity. Finally, to rationalize the obtained results, molecular docking studies were performed. The results of the pharmacological studies showed that 3e, 4j, and 4n were the most active and promising derivatives for the serotonin receptor considered in this study.
Collapse
Affiliation(s)
- Elisa Magli
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Ewa Kędzierska
- Department of Pharmacology and Pharmacodynamics, Faculty of Pharmacy with Division of Medical Analytics, Medical University of Lublin, Lublin, Poland
| | - Agnieszka A Kaczor
- Department of Synthesis and Chemical Technology of Pharmaceutical Substances with Computer Modeling Laboratory, Faculty of Pharmacy, Medical University of Lublin, Lublin, Poland.,School of Pharmacy, University of Eastern Finland, Kuopio, Finland
| | - Anna Bielenica
- Department of Biochemistry, Medical University of Warsaw, Warsaw, Poland
| | - Beatrice Severino
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Ewa Gibuła-Tarłowska
- Department of Pharmacology and Pharmacodynamics, Faculty of Pharmacy with Division of Medical Analytics, Medical University of Lublin, Lublin, Poland
| | - Jolanta H Kotlińska
- Department of Pharmacology and Pharmacodynamics, Faculty of Pharmacy with Division of Medical Analytics, Medical University of Lublin, Lublin, Poland
| | - Angela Corvino
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Rosa Sparaco
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Giovanna Esposito
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Stefania Albrizio
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Elisa Perissutti
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Francesco Frecentese
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Anna Leśniak
- Department of Pharmacodynamics, Centre for Preclinical Research and Technology, Faculty of Pharmacy, Medical University of Warsaw, Warsaw, Poland
| | - Magdalena Bujalska-Zadrożny
- Department of Pharmacodynamics, Centre for Preclinical Research and Technology, Faculty of Pharmacy, Medical University of Warsaw, Warsaw, Poland
| | - Marta Struga
- Department of Biochemistry, Medical University of Warsaw, Warsaw, Poland
| | - Raffaele Capasso
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Vincenzo Santagada
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Giuseppe Caliendo
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Ferdinando Fiorino
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| |
Collapse
|
8
|
Narayanaswami V, Tong J, Fiorino F, Severino B, Sparaco R, Magli E, Giordano F, Bloomfield PM, Prabhakaran J, Mann JJ, Vasdev N, Dahl K, Kumar JSD. Synthesis, in vitro and in vivo evaluation of 11C-O-methylated arylpiperazines as potential serotonin 1A (5-HT 1A) receptor antagonist radiotracers. EJNMMI Radiopharm Chem 2020; 5:13. [PMID: 32430632 PMCID: PMC7237647 DOI: 10.1186/s41181-020-00096-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2020] [Accepted: 04/23/2020] [Indexed: 01/23/2023] Open
Abstract
Background Serotonin 1A (5-HT1A) receptors are implicated in the pathogenesis of several psychiatric and neurodegenerative disorders motivating the development of suitable radiotracers for in vivo positron emission tomography (PET) neuroimaging. The gold standard PET imaging agent for this target is [carbonyl-11C]WAY-100635, labeled via a technically challenging multi-step reaction that has limited its widespread use. While several antagonist and agonist-based PET radiotracers for 5-HT 1A receptors have been developed, their clinical translation has been hindered by methodological challenges and/or and non-specific binding. As a result, there is continued interest in the development of new and more selective 5-HT1A PET tracers having a relatively easier and reliable radiosynthesis process for routine production and with favorable metabolism to facilitate tracer-kinetic modeling. The purpose of the current study was to develop and characterize a radioligand with suitable characteristics for imaging 5-HT1A receptors in the brain. The current study reports the in vitro characterization and radiosyntheses of three candidate 5-HT1A receptor antagonists, DF-100 (1), DF-300 (2) and DF-400 (3), to explore their suitability as potential PET radiotracers. Results Syntheses of 1–3 and corresponding precursors for radiolabeling were achieved from isonicotinic, picolinic acid or picolino nitrile. In vitro binding studies demonstrated nanomolar affinity of the compounds for 5-HT1A receptors. Binding of 1–3 for other biogenic amines, neurotransmitter receptors, and transporters was negligible with the exception of moderate affinities for α1-adrenergic receptors (4–6-fold less potent than that for 5-HT1A receptor). Radioligands [11C]1–3 were efficiently prepared by 11C-O-methylation of the corresponding phenolic precursor in non-decay corrected radiochemical yields of 7–11% with > 99% chemical and radiochemical purities. Dynamic PET studies in rats demonstrated negligible brain uptake of [11C]1 and [11C]2. In contrast, significant brain uptake of [11C]3 was observed with an early peak SUV of 4–5. However, [11C]3 displayed significant off-target binding attributed to α1-adrenergic receptors based on regional distribution (thalamus>hippocampus) and blocking studies. Conclusion Despite efficient radiolabeling, results from PET imaging experiments limit the application of [11C]3 for in vivo quantification of 5-HT1A receptors. Nevertheless, derivatives of compound 3 may provide a scaffold for alternative PET radiotracers with improved selectivity for 5-HT 1A receptors or α1-adrenergic receptors.
Collapse
Affiliation(s)
- Vidya Narayanaswami
- Azrieli Centre for Neuro-Radiochemistry, Research Imaging Centre & Preclinical Imaging, Centre for Addiction and Mental Health, Toronto, Ontario, M5T-1R8, Canada
| | - Junchao Tong
- Azrieli Centre for Neuro-Radiochemistry, Research Imaging Centre & Preclinical Imaging, Centre for Addiction and Mental Health, Toronto, Ontario, M5T-1R8, Canada
| | - Ferdinando Fiorino
- Department of Pharmacy, University of Naples, Via D. Montesano, 49, 8013, Naples, Italy
| | - Beatrice Severino
- Department of Pharmacy, University of Naples, Via D. Montesano, 49, 8013, Naples, Italy
| | - Rosa Sparaco
- Department of Pharmacy, University of Naples, Via D. Montesano, 49, 8013, Naples, Italy
| | - Elisa Magli
- Department of Pharmacy, University of Naples, Via D. Montesano, 49, 8013, Naples, Italy
| | - Flavia Giordano
- Department of Pharmacy, University of Naples, Via D. Montesano, 49, 8013, Naples, Italy
| | - Peter M Bloomfield
- Azrieli Centre for Neuro-Radiochemistry, Research Imaging Centre & Preclinical Imaging, Centre for Addiction and Mental Health, Toronto, Ontario, M5T-1R8, Canada
| | - Jaya Prabhakaran
- Molecular Imaging and Neuropathology Division, New York State Psychiatric Institute, New York, USA
| | - J John Mann
- Molecular Imaging and Neuropathology Division, New York State Psychiatric Institute, New York, USA.,Department of Psychiatry, Columbia University Medical Center, New York, USA
| | - Neil Vasdev
- Azrieli Centre for Neuro-Radiochemistry, Research Imaging Centre & Preclinical Imaging, Centre for Addiction and Mental Health, Toronto, Ontario, M5T-1R8, Canada.,Department of Psychiatry, University of Toronto, Toronto, Ontario, M5T-1R8, Canada
| | - Kenneth Dahl
- Azrieli Centre for Neuro-Radiochemistry, Research Imaging Centre & Preclinical Imaging, Centre for Addiction and Mental Health, Toronto, Ontario, M5T-1R8, Canada.
| | - J S Dileep Kumar
- Molecular Imaging and Neuropathology Division, New York State Psychiatric Institute, New York, USA.
| |
Collapse
|
9
|
Magli E, Severino B, Corvino A, Perissutti E, Frecentese F, Saccone I, Giordano F, Castro M, Brea J, Loza MI, Santagada V, Caliendo G, Fiorino F. New Serotoninergic Ligands Containing Indolic and Methyl Indolic Nuclei: Synthesis and In Vitro Pharmacological Evaluation. Med Chem 2019; 16:517-530. [PMID: 31203804 DOI: 10.2174/1573406415666190613153220] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2019] [Revised: 04/23/2019] [Accepted: 04/29/2019] [Indexed: 11/22/2022]
Abstract
BACKGROUND Serotonin is an important biogenic amine and is implicated in wideranging physiological and physiopathological processes. Pharmacological manipulation of the serotoninergic system is believed to have a great therapeutic potential. OBJECTIVES In order to identify selective ligands for 5-HT1A, 5-HT2A and 5-HT2C receptors two series of 4-substituted piperazine derivatives, bearing indolic or methyl indolic nuclei, were synthesized. METHODS All the compounds, synthesized by standard solution methods, were evaluated for 5- HT1A, 5-HT2A and 5-HT2C receptors. The highest affine and selective compounds have been evaluated also on dopaminergic (D1 and D2) and adrenergic (α1A and α2A) receptors. RESULTS Several of the newly synthesized molecules showed affinity in the nanomolar range for 5- HT1A, 5-HT2A and 5-HT2C receptors and moderate to no affinity for other relevant receptors (D1, D2, α1A and α2A). CONCLUSION Compounds 7f and 10a showed a nanomolar affinity towards 5-HT1A with an in vitro pharmacologic profile compatible with antipsychotic drugs.
Collapse
Affiliation(s)
- Elisa Magli
- Dipartimento di Farmacia, Universita degli Studi di Napoli "Federico II", Via D. Montesano, 49, 80131, Napoli, Italy
| | - Beatrice Severino
- Dipartimento di Farmacia, Universita degli Studi di Napoli "Federico II", Via D. Montesano, 49, 80131, Napoli, Italy
| | - Angela Corvino
- Dipartimento di Farmacia, Universita degli Studi di Napoli "Federico II", Via D. Montesano, 49, 80131, Napoli, Italy
| | - Elisa Perissutti
- Dipartimento di Farmacia, Universita degli Studi di Napoli "Federico II", Via D. Montesano, 49, 80131, Napoli, Italy
| | - Francesco Frecentese
- Dipartimento di Farmacia, Universita degli Studi di Napoli "Federico II", Via D. Montesano, 49, 80131, Napoli, Italy
| | - Irene Saccone
- Dipartimento di Farmacia, Universita degli Studi di Napoli "Federico II", Via D. Montesano, 49, 80131, Napoli, Italy
| | - Flavia Giordano
- Dipartimento di Farmacia, Universita degli Studi di Napoli "Federico II", Via D. Montesano, 49, 80131, Napoli, Italy
| | - Marián Castro
- USEF Screening Platform-BioFarma Research Group, Center for Research in Molecular Medicine and Chronic Diseases, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
| | - José Brea
- USEF Screening Platform-BioFarma Research Group, Center for Research in Molecular Medicine and Chronic Diseases, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
| | - María I Loza
- USEF Screening Platform-BioFarma Research Group, Center for Research in Molecular Medicine and Chronic Diseases, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
| | - Vincenzo Santagada
- Dipartimento di Farmacia, Universita degli Studi di Napoli "Federico II", Via D. Montesano, 49, 80131, Napoli, Italy
| | - Giuseppe Caliendo
- Dipartimento di Farmacia, Universita degli Studi di Napoli "Federico II", Via D. Montesano, 49, 80131, Napoli, Italy
| | - Ferdinando Fiorino
- Dipartimento di Farmacia, Universita degli Studi di Napoli "Federico II", Via D. Montesano, 49, 80131, Napoli, Italy
| |
Collapse
|
10
|
Magli E, Kędzierska E, Kaczor AA, Severino B, Corvino A, Perissutti E, Frecentese F, Saccone I, Massarelli P, Gibuła‐Tarłowska E, Kotlińska JH, Santagada V, Caliendo G, Fiorino F. Synthesis, docking studies, and pharmacological evaluation of 5HT
2C
ligands containing the
N
′‐cyanoisonicotinamidine or
N
′‐cyanopicolinamidine nucleus. Arch Pharm (Weinheim) 2019; 352:e1800373. [DOI: 10.1002/ardp.201800373] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2018] [Revised: 02/07/2019] [Accepted: 02/09/2019] [Indexed: 01/18/2023]
Affiliation(s)
- Elisa Magli
- Dipartimento di FarmaciaUniversità di Napoli “Federico II”Naples Italy
| | - Ewa Kędzierska
- Department of Pharmacology and Pharmacodynamics, Faculty of Pharmacy with Division of Medical AnalyticsMedical University of LublinLublin Poland
| | - Agnieszka A. Kaczor
- Department of Synthesis and Chemical Technology of Pharmaceutical Substances with Computer Modeling Laboratory, Faculty of Pharmacy with Division of Medical AnalyticsMedical University of LublinLublin Poland
- School of PharmacyUniversity of Eastern FinlandKuopio Finland
| | - Beatrice Severino
- Dipartimento di FarmaciaUniversità di Napoli “Federico II”Naples Italy
| | - Angela Corvino
- Dipartimento di FarmaciaUniversità di Napoli “Federico II”Naples Italy
| | - Elisa Perissutti
- Dipartimento di FarmaciaUniversità di Napoli “Federico II”Naples Italy
| | | | - Irene Saccone
- Dipartimento di FarmaciaUniversità di Napoli “Federico II”Naples Italy
| | - Paola Massarelli
- Dipartimento di Scienze Mediche, Chirurgiche e NeuroscienzeUniversità di SienaSiena Italy
| | - Ewa Gibuła‐Tarłowska
- Department of Pharmacology and Pharmacodynamics, Faculty of Pharmacy with Division of Medical AnalyticsMedical University of LublinLublin Poland
| | - Jolanta H. Kotlińska
- Department of Pharmacology and Pharmacodynamics, Faculty of Pharmacy with Division of Medical AnalyticsMedical University of LublinLublin Poland
| | | | - Giuseppe Caliendo
- Dipartimento di FarmaciaUniversità di Napoli “Federico II”Naples Italy
| | | |
Collapse
|
11
|
Kędzierska E, Fiorino F, Magli E, Poleszak E, Wlaź P, Orzelska-Górka J, Knap B, Kotlińska JH. New arylpiperazine derivatives with antidepressant-like activity containing isonicotinic and picolinic nuclei: evidence for serotonergic system involvement. Naunyn Schmiedebergs Arch Pharmacol 2019; 392:743-754. [DOI: 10.1007/s00210-019-01620-7] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2018] [Accepted: 01/16/2019] [Indexed: 01/09/2023]
|
12
|
Kędzierska E, Fiorino F, Gibuła E, Corvino A, Giordano F, Herbet M, Dudka J, Poleszak E, Wlaź P, Kotlińska JH. Anxiolytic‐like effects of the new arylpiperazine derivatives containing isonicotinic and picolinic nuclei: behavioral and biochemical studies. Fundam Clin Pharmacol 2019; 33:254-266. [DOI: 10.1111/fcp.12443] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2018] [Revised: 11/14/2018] [Accepted: 11/26/2018] [Indexed: 12/19/2022]
Affiliation(s)
- Ewa Kędzierska
- Department of Pharmacology and Pharmacodynamics Faculty of Pharmacy with Division of Medical Analytics Medical University of Lublin Chodźki 4a 20‐093 Lublin Poland
| | - Ferdinando Fiorino
- Department of Pharmacy University of Naples Federico II Via D. Montesano 49 80131 Naples Italy
| | - Ewa Gibuła
- Department of Pharmacology and Pharmacodynamics Faculty of Pharmacy with Division of Medical Analytics Medical University of Lublin Chodźki 4a 20‐093 Lublin Poland
| | - Angela Corvino
- Department of Pharmacy University of Naples Federico II Via D. Montesano 49 80131 Naples Italy
| | - Flavia Giordano
- Department of Pharmacy University of Naples Federico II Via D. Montesano 49 80131 Naples Italy
| | - Mariola Herbet
- Department of Toxicology Faculty of Pharmacy with Division of Medical Analytics Medical University of Lublin Chodźki 8 20‐093 Lublin Poland
| | - Jarosław Dudka
- Department of Toxicology Faculty of Pharmacy with Division of Medical Analytics Medical University of Lublin Chodźki 8 20‐093 Lublin Poland
| | - Ewa Poleszak
- Department of Applied Pharmacy Faculty of Pharmacy with Division of Medical Analytics Medical University of Lublin Chodźki 1 20‐093 Lublin Poland
| | - Piotr Wlaź
- Department of Animal Physiology Faculty of Biology and Biotechnology Maria Curie‐Skłodowska University Akademicka 19 20‐033 Lublin Poland
| | - Jolanta H. Kotlińska
- Department of Pharmacology and Pharmacodynamics Faculty of Pharmacy with Division of Medical Analytics Medical University of Lublin Chodźki 4a 20‐093 Lublin Poland
| |
Collapse
|
13
|
Fiorino F, Magli E, Kędzierska E, Ciano A, Corvino A, Severino B, Perissutti E, Frecentese F, Di Vaio P, Saccone I, Izzo AA, Capasso R, Massarelli P, Rossi I, Orzelska-Gòrka J, Kotlińska JH, Santagada V, Caliendo G. New 5-HT1A, 5HT2A and 5HT2C receptor ligands containing a picolinic nucleus: Synthesis, in vitro and in vivo pharmacological evaluation. Bioorg Med Chem 2017; 25:5820-5837. [DOI: 10.1016/j.bmc.2017.09.018] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2017] [Revised: 09/05/2017] [Accepted: 09/13/2017] [Indexed: 02/02/2023]
|